Boris Brill
Impact in
- Virology top 10%
- HIV Research and Treatment
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
- Oncology 16
- Cytokine Signaling Pathways and Interactions 9
- Cancer Cells and Metastasis 4
- Cancer-related Molecular Pathways 3
- CAR-T cell therapy research 3
-
- Epigenetics and DNA Methylation 4
- Co-authors
- Bernd Groner (16 shared papers)Corina Borghouts (8 shared papers)Vida Vafaizadeh (5 shared papers)Franz Rödel (2 shared papers)Judith Bergs (2 shared papers)Peter Bader (1 shared paper)Sabine Huenecke (1 shared paper)Evelyn Ullrich (1 shared paper)
- Journals
- Hormone Molecular Biology and Clinical Investigation (4 papers)Experimental Dermatology (1 paper)Experimental Hematology (1 paper)Laboratory Animals (1 paper)Women s Health (1 paper)
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
Boris Brill
32 papers receiving 577 citations
Peers
Comparison fields: 5 of 78
- Virology 49
- Hematology 103
- Immunology 162
- Oncology 159
- Genetics 53
Countries citing papers authored by Boris Brill
This map shows the geographic impact of Boris Brill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Brill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Brill more than expected).
Fields of papers citing papers by Boris Brill
This network shows the impact of papers produced by Boris Brill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Brill. The network helps show where Boris Brill may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Brill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 84 | |
| 2 | 2018 | 55 | |
| 3 | 2014 | 50 | |
| 4 | 2015 | 36 | |
| 5 | 2014 | 36 | |
| 6 | 2010 | 33 | |
| 7 | 2014 | 30 | |
| 8 | 2007 | 29 | |
| 9 | 2012 | 25 | |
| 10 | 2004 | 24 | |
| 11 | 2012 | 24 | |
| 12 | 2013 | 20 | |
| 13 | 2012 | 19 | |
| 14 | 2008 | 19 | |
| 15 | 2015 | 15 | |
| 16 | 2012 | 14 | |
| 17 | 2014 | 13 | |
| 18 | 2019 | 11 | |
| 19 | 2012 | 10 | |
| 20 | 2011 | 8 |
About Boris Brill
Boris Brill is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Hematology, having authored 36 papers that have together received 593 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (9 papers), Cancer Cells and Metastasis (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Epigenetics and DNA Methylation (4 papers), T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers), Cancer-related Molecular Pathways (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Virology (49 citations), Hematology (103 citations), Immunology (162 citations), Oncology (159 citations) and Genetics (53 citations). Boris Brill has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include Bernd Groner, Corina Borghouts, Vida Vafaizadeh, Franz Rödel, Judith Bergs, Peter Bader, Sabine Huenecke, Evelyn Ullrich, Juliane Wagner and Winfried S. Wels. Their work appears in journals such as Hormone Molecular Biology and Clinical Investigation, Experimental Dermatology, Experimental Hematology, Laboratory Animals and Women s Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.